Company registration number 12764197 (England and Wales)
ESMAIL MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
ESMAIL MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
ESMAIL MEDICAL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Intangible assets
4
92,832
107,208
Tangible assets
5
70,461
6,060
163,293
113,268
Current assets
Stocks
1,300
3,800
Debtors
6
733,624
570,227
Cash at bank and in hand
60,317
261,374
795,241
835,401
Creditors: amounts falling due within one year
7
(69,220)
(156,876)
Net current assets
726,021
678,525
Total assets less current liabilities
889,314
791,793
Provisions for liabilities
8
(597)
(2,004)
Net assets
888,717
789,789
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
888,617
789,689
Total equity
888,717
789,789
ESMAIL MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2026
31 March 2026
- 2 -

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 4 June 2026 and are signed on its behalf by:
Dr Z Esmail
Director
Company registration number 12764197 (England and Wales)
ESMAIL MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
1
Accounting policies
Company information

Esmail Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1A City Gate, 185 Dyke Road, Hove, BN3 1TL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Other investments
Fair value through profit and loss
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% straight line
Computers
33% straight line
Motor vehicles
20% straight line
ESMAIL MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 4 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

ESMAIL MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

ESMAIL MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 6 -
1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
ESMAIL MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 7 -
4
Intangible fixed assets
Other investments
£
Cost
At 1 April 2025
107,208
Revaluation
(9,082)
At 31 March 2026
98,126
Amortisation and impairment
At 1 April 2025
-
0
Impairment losses
5,294
At 31 March 2026
5,294
Carrying amount
At 31 March 2026
92,832
At 31 March 2025
107,208
5
Tangible fixed assets
Plant and equipment
Computers
Motor vehicles
Total
£
£
£
£
Cost
At 1 April 2025
9,230
13,340
-
0
22,570
Additions
300
1,564
83,018
84,882
Disposals
-
0
(1,199)
-
0
(1,199)
At 31 March 2026
9,530
13,705
83,018
106,253
Depreciation and impairment
At 1 April 2025
5,124
11,386
-
0
16,510
Depreciation charged in the year
1,906
1,563
16,604
20,073
Eliminated in respect of disposals
-
0
(791)
-
0
(791)
At 31 March 2026
7,030
12,158
16,604
35,792
Carrying amount
At 31 March 2026
2,500
1,547
66,414
70,461
At 31 March 2025
4,106
1,954
-
0
6,060
ESMAIL MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 8 -
6
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
-
0
62,171
Other debtors
733,624
508,056
733,624
570,227
7
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
-
0
198
Taxation and social security
29,881
152,307
Other creditors
39,339
4,371
69,220
156,876
8
Provisions for liabilities
2026
2025
£
£
Deferred tax liabilities
597
2,004
9
Contingent liabilities

At the balance sheet date, the company was committed to making non-cancellable operating lease payments totalling £12,874 (2025: £21,961) in respect of a motor vehicle lease

10
Related party transactions
Transactions with related parties

At the balance sheet date, the company was owed £325,000 (2025: £325,000) by a company under common control. This balance is included within other debtors. There are no set repayment terms nor interest charged.

 

At the balance sheet date, the company owed £35,085 (2025: the company was owed £20,000) to a second company under common control. This balance is included within other creditors. There are no set repayment terms nor interest charged.

11
Directors' transactions

At the start of the year, a director owed the company £134,977. During the year, further amounts of £183,513 (2025: £134,977) were advanced to the director. The total outstanding balance due to the company at the balance sheet date was £318,490. There are no set repayment terms and interest has been charged at HMRC's official rate of interest.

2026-03-312025-04-01falsefalsefalse04 June 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityDr Z EsmailDr S Ameen127641972025-04-012026-03-31127641972026-03-31127641972025-03-3112764197core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2026-03-3112764197core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-03-3112764197core:PlantMachinery2026-03-3112764197core:ComputerEquipment2026-03-3112764197core:MotorVehicles2026-03-3112764197core:PlantMachinery2025-03-3112764197core:ComputerEquipment2025-03-3112764197core:MotorVehicles2025-03-3112764197core:CurrentFinancialInstrumentscore:WithinOneYear2026-03-3112764197core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3112764197core:CurrentFinancialInstruments2026-03-3112764197core:CurrentFinancialInstruments2025-03-3112764197core:ShareCapital2026-03-3112764197core:ShareCapital2025-03-3112764197core:RetainedEarningsAccumulatedLosses2026-03-3112764197core:RetainedEarningsAccumulatedLosses2025-03-3112764197bus:Director12025-04-012026-03-3112764197core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3112764197core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-04-012026-03-3112764197core:PlantMachinery2025-04-012026-03-3112764197core:ComputerEquipment2025-04-012026-03-3112764197core:MotorVehicles2025-04-012026-03-31127641972024-04-012025-03-3112764197core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-03-3112764197core:PlantMachinery2025-03-3112764197core:ComputerEquipment2025-03-3112764197core:MotorVehicles2025-03-31127641972025-03-3112764197bus:PrivateLimitedCompanyLtd2025-04-012026-03-3112764197bus:SmallCompaniesRegimeForAccounts2025-04-012026-03-3112764197bus:FRS1022025-04-012026-03-3112764197bus:AuditExemptWithAccountantsReport2025-04-012026-03-3112764197bus:Director22025-04-012026-03-3112764197bus:FullAccounts2025-04-012026-03-31xbrli:purexbrli:sharesiso4217:GBP